These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 35029940)

  • 41. Management of Orthostatic Hypotension in Parkinson's Disease.
    Fanciulli A; Leys F; Falup-Pecurariu C; Thijs R; Wenning GK
    J Parkinsons Dis; 2020; 10(s1):S57-S64. PubMed ID: 32716319
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Orthostatic Blood Pressure Change, Dizziness, and Risk of Dementia in the ARIC Study.
    Ma Y; Zhang Y; Coresh J; Viswanathan A; Sullivan KJ; Walker KA; Liu C; Lipsitz LA; Selvin E; Sharrett AR; Gottesman RF; Blacker D; Hofman A; Windham BG; Juraschek SP
    Hypertension; 2024 Jan; 81(1):96-106. PubMed ID: 37869909
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hypotension unawareness in profound orthostatic hypotension.
    Arbogast SD; Alshekhlee A; Hussain Z; McNeeley K; Chelimsky TC
    Am J Med; 2009 Jun; 122(6):574-80. PubMed ID: 19486719
    [TBL] [Abstract][Full Text] [Related]  

  • 44. EFNS guidelines on the diagnosis and management of orthostatic hypotension.
    Lahrmann H; Cortelli P; Hilz M; Mathias CJ; Struhal W; Tassinari M
    Eur J Neurol; 2006 Sep; 13(9):930-6. PubMed ID: 16930356
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Current concepts in orthostatic hypotension management.
    Arnold AC; Shibao C
    Curr Hypertens Rep; 2013 Aug; 15(4):304-12. PubMed ID: 23832761
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Orthostatic hypotension: evaluation and treatment.
    Maule S; Papotti G; Naso D; Magnino C; Testa E; Veglio F
    Cardiovasc Hematol Disord Drug Targets; 2007 Mar; 7(1):63-70. PubMed ID: 17346129
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The comparative usefulness of orthostatic testing and tilt table testing in the evaluation of autonomic-associated dizziness.
    Faraji F; Kinsella LJ; Rutledge JC; Mikulec AA
    Otol Neurotol; 2011 Jun; 32(4):654-9. PubMed ID: 21358449
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of History of Dizziness and Long-term Adverse Outcomes With Early vs Later Orthostatic Hypotension Assessment Times in Middle-aged Adults.
    Juraschek SP; Daya N; Rawlings AM; Appel LJ; Miller ER; Windham BG; Griswold ME; Heiss G; Selvin E
    JAMA Intern Med; 2017 Sep; 177(9):1316-1323. PubMed ID: 28738139
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of orthostatic hypotension with sleeping in the head-up tilt position, alone and in combination with fludrocortisone.
    Ten Harkel AD; Van Lieshout JJ; Wieling W
    J Intern Med; 1992 Aug; 232(2):139-45. PubMed ID: 1506810
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Droxidopa: a review of its use in symptomatic neurogenic orthostatic hypotension.
    Keating GM
    Drugs; 2015 Feb; 75(2):197-206. PubMed ID: 25559422
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Titrating droxidopa to maximize symptomatic benefit in a patient with Parkinson disease and neurogenic orthostatic hypotension.
    Gupta F; Karabin B; Mehdirad A
    Clin Auton Res; 2017 Jul; 27(Suppl 1):15-16. PubMed ID: 28699047
    [No Abstract]   [Full Text] [Related]  

  • 52. Droxidopa and Reduced Falls in a Trial of Parkinson Disease Patients With Neurogenic Orthostatic Hypotension.
    Hauser RA; Heritier S; Rowse GJ; Hewitt LA; Isaacson SH
    Clin Neuropharmacol; 2016; 39(5):220-6. PubMed ID: 27332626
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine.
    Jankovic J; Gilden JL; Hiner BC; Kaufmann H; Brown DC; Coghlan CH; Rubin M; Fouad-Tarazi FM
    Am J Med; 1993 Jul; 95(1):38-48. PubMed ID: 7687093
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alpha sympathomimetic treatment of autonomic insufficiency with orthostatic hypotension.
    Fouad-Tarazi FM; Okabe M; Goren H
    Am J Med; 1995 Dec; 99(6):604-10. PubMed ID: 7503082
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Supine plasma NE predicts the pressor response to droxidopa in neurogenic orthostatic hypotension.
    Palma JA; Norcliffe-Kaufmann L; Martinez J; Kaufmann H
    Neurology; 2018 Oct; 91(16):e1539-e1544. PubMed ID: 30232253
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Distribution and observed associations of orthostatic blood pressure changes in elderly general medicine outpatients.
    Robertson D; DesJardin JA; Lichtenstein MJ
    Am J Med Sci; 1998 May; 315(5):287-95. PubMed ID: 9587084
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial.
    Kaufmann H; Freeman R; Biaggioni I; Low P; Pedder S; Hewitt LA; Mauney J; Feirtag M; Mathias CJ;
    Neurology; 2014 Jul; 83(4):328-35. PubMed ID: 24944260
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Management of neurogenic orthostatic hypotension.
    Arbique D; Cheek D; Welliver M; Vongpatanasin W
    J Am Med Dir Assoc; 2014 Apr; 15(4):234-9. PubMed ID: 24388946
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Orthostatic hypotension in elderly women with congestive heart failure.
    Potocka-Plazak K; Plazak W
    Aging (Milano); 2001 Oct; 13(5):378-84. PubMed ID: 11820711
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Orthostatic hypotension in the elderly].
    Ferrer-Gila T; Rízea C
    Rev Neurol; 2013 Mar; 56(6):337-43. PubMed ID: 23483469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.